Many protein coding genes from the newly identified ceRNA network were reported as oncogenes and/or tumor suppressors participating in bladder cancer development and progression, such as CDKN1A, HMGA2 and MYC, which also was considered as promising therapeutic targets for bladder cancer [34–36]. The gene discussed is HMGA2; the disease is urinary bladder carcinoma.